{"id":4293,"date":"2026-09-22T03:38:22","date_gmt":"2026-09-22T00:38:22","guid":{"rendered":"https:\/\/www.btinteraktif.com\/onkoloji-ve-klinik-arastirmalari-icin-yapay-zeka-gelistiren-altis-labs-25-milyon-dolar-yatirim-aldi\/"},"modified":"2026-09-22T03:38:22","modified_gmt":"2026-09-22T00:38:22","slug":"onkoloji-ve-klinik-arastirmalari-icin-yapay-zeka-gelistiren-altis-labs-25-milyon-dolar-yatirim-aldi","status":"publish","type":"post","link":"https:\/\/www.btinteraktif.com\/onkoloji-ve-klinik-arastirmalari-icin-yapay-zeka-gelistiren-altis-labs-25-milyon-dolar-yatirim-aldi\/","title":{"rendered":"Onkoloji ve Klinik Ara\u015ft\u0131rmalar\u0131 \u0130\u00e7in Yapay Zeka Geli\u015ftiren Altis Labs, 25 Milyon Dolar Yat\u0131r\u0131m Ald\u0131"},"content":{"rendered":"

Kanada merkezli biyoteknoloji \u015firketi Altis Labs, onkoloji ve klinik ara\u015ft\u0131rmalar alan\u0131nda geli\u015ftirdi\u011fi yapay zeka teknolojileri i\u00e7in 25 milyon dolar A serisi yat\u0131r\u0131m ald\u0131. Bu yat\u0131r\u0131m turuna sekt\u00f6rde \u00f6nde gelen sa\u011fl\u0131k yat\u0131r\u0131m \u015firketleri OrbiMed ve Qiming Venture Partners USA \u00f6nc\u00fcl\u00fck ederken; Innovation Endeavors, Benchstrength, Fusion Fund ve Cancer Breakthrough Fund da kat\u0131ld\u0131.<\/p>\n

Altis Labs\u2019in Yenilik\u00e7i Yakla\u015f\u0131m\u0131<\/h2>\n

2019 y\u0131l\u0131nda Felix Baldauf-Lenschen taraf\u0131ndan kurulan Altis Labs, kanser ila\u00e7lar\u0131n\u0131n klinik ara\u015ft\u0131rmalar\u0131nda kullan\u0131lan t\u0131bbi g\u00f6r\u00fcnt\u00fcleri yapay zeka ile analiz eden \u00f6zg\u00fcn bir teknoloji geli\u015ftirdi. \u015eirketin amac\u0131, ila\u00e7lar\u0131n hastalar \u00fczerindeki etkisini mevcut y\u00f6ntemlere k\u0131yasla \u00e7ok daha erken ve do\u011fru \u015fekilde tespit etmek. B\u00f6ylece ila\u00e7 geli\u015ftiricilerin klinik fazlardaki kritik kararlar\u0131n\u0131 h\u0131zland\u0131rmak hedefleniyor.<\/p>\n

\u015eirketin geli\u015ftirdi\u011fi IPRO adl\u0131 yapay zeka modeli, klinik ara\u015ft\u0131rmalar kapsam\u0131nda rutin olarak \u00e7ekilen radyoloji g\u00f6r\u00fcnt\u00fclerini inceleyerek hastalar\u0131n sa\u011fkal\u0131m s\u00fcreleri ve tedaviye yan\u0131tlar\u0131n\u0131 tahmin edebiliyor. Model yaln\u0131zca t\u00fcm\u00f6r\u00fcn k\u00fc\u00e7\u00fcl\u00fcp k\u00fc\u00e7\u00fclmedi\u011fine de\u011fil, g\u00f6r\u00fcnt\u00fclerdeki verileri ger\u00e7ek hastalar\u0131n uzun vadeli sonu\u00e7lar\u0131yla ili\u015fkilendirerek tedavinin etkisini daha derinlemesine analiz ediyor. Bu sayede geleneksel y\u00f6ntemlerin g\u00f6zden ka\u00e7\u0131rd\u0131\u011f\u0131 erken tedavi etkileri tespit edilebiliyor.<\/p>\n

Yat\u0131r\u0131m\u0131n Kullan\u0131m Alanlar\u0131 ve Gelecek Vizyonu<\/h2>\n

Altis Labs yeni ald\u0131\u011f\u0131 yat\u0131r\u0131m\u0131, yapay zeka modellerini farkl\u0131 kanser t\u00fcrlerine geni\u015fletmek, k\u00fcresel biyofarma \u015firketleri ile ticari uygulamalar\u0131n\u0131 b\u00fcy\u00fctmek ve yapay zeka destekli sonlan\u0131m noktalar\u0131n\u0131 onkoloji klinik ara\u015ft\u0131rmalar\u0131nda yayg\u0131nla\u015ft\u0131rmak i\u00e7in kullanacak. \u015eirketin sundu\u011fu teknoloji, biyofarmalar\u0131n Faz 1’den Faz 4’e kadar olan t\u00fcm klinik ara\u015ft\u0131rmalar\u0131nda kullan\u0131labiliyor.<\/p>\n

Bu yeni \u00f6l\u00e7\u00fcm y\u00f6ntemleri sayesinde ila\u00e7lar\u0131n etkinli\u011fi \u00e7ok daha erken de\u011ferlendirilebilecek, tedavisi ba\u015far\u0131s\u0131z olabilecek ila\u00e7 adaylar\u0131 erken elenecek ve etkili tedaviler hastalara daha h\u0131zl\u0131 ula\u015ft\u0131r\u0131lacak. Altis Labs bu sayede kanser tedavisi alan\u0131nda klinik ara\u015ft\u0131rmalar\u0131n ba\u015far\u0131s\u0131n\u0131 art\u0131rmay\u0131 ve hastalar\u0131n ya\u015fam kalitesini y\u00fckseltmeyi hedefliyor.<\/p>\n

Kaynak: Webrazzi Yapay Zeka<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Kanser ara\u015ft\u0131rmalar\u0131nda yapay zekay\u0131 kullanan Altis Labs, 25 milyon dolarl\u0131k \u00f6nemli bir yat\u0131r\u0131m turunu tamamlad\u0131. \u015eirket, geli\u015ftirdi\u011fi IPRO modeli ile klinik ara\u015ft\u0131rmalarda ila\u00e7lar\u0131n etkinli\u011fini daha erken ve do\u011fru \u015fekilde tespit etmeyi ama\u00e7l\u0131yor.<\/p>\n","protected":false},"author":0,"featured_media":4294,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,146,96,104],"tags":[1213,1216,1215,1214,108,235],"class_list":["post-4293","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genel","category-saglik","category-teknoloji","category-yapay-zeka","tag-altis-labs","tag-biyoteknoloji","tag-klinik-arastirmalar","tag-onkoloji","tag-yapay-zeka","tag-yatirim"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/posts\/4293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/comments?post=4293"}],"version-history":[{"count":0,"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/posts\/4293\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/media\/4294"}],"wp:attachment":[{"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/media?parent=4293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/categories?post=4293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.btinteraktif.com\/bt-json\/wp\/v2\/tags?post=4293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}